M2-polarised macrophages in infantile haemangiomas: Correlation with promoted angiogenesis

Journal of Clinical Pathology

Volumn 66, Issue 12, 2013, Pages 1058-1064

  Wang, Feng Qin ^a   Chen, Gang ^a   Zhu, Jun Yi ^a   Zhang, Wei ^a   Ren, Jian Gang ^a   Liu, Hui ^a   Sun, Zhi Jun ^a   Jia, Jun ^a   Zhao, Yi Fang ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD163 ANTIGEN; CD68 ANTIGEN; COLONY STIMULATING FACTOR 1; KI 67 ANTIGEN; VASCULOTROPIN; CD68 ANTIGEN, HUMAN; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; CAPILLARY HEMANGIOMA; CELL DENSITY; CELL INFILTRATION; CELL POLARITY; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; IMMUNOFLUORESCENCE TEST; INFANT; M2 POLARIZED MACROPHAGE; MACROPHAGE; MALE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SECRETION; TUMOR VASCULARIZATION; CYTOLOGY; DISEASE COURSE; FLUORESCENT ANTIBODY TECHNIQUE; HEMANGIOMA; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; IMMUNOPATHOLOGY; METABOLISM; MOLECULAR PATHOLOGY; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; PROGNOSIS; VASCULARIZATION;

IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; MOLECULAR PATHOLOGY;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL POLARITY; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HEMANGIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; KI-67 ANTIGEN; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MALE; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; PROGNOSIS; RECEPTORS, CELL SURFACE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84892788608     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2012-201286     Document Type: Article

References (37)

1. Pandey A, Gangopadhyay AN, Gopal SC, et al. Twenty years' experience of steroids in infantile hemangioma - a developing country's perspective. J Pediatr Surg 2009;44:688-94.
2. Couto RA, Maclellan RA, Zurakowski D, et al. Infantile hemangioma: clinical assessment of the involuting phase and implications for management. Plast Reconstr Surg 2012;130(3):619-24.
3. Ritter MR, Reinisch J, Friedlander SF, et al. Myeloid cells in infantile hemangioma. Am J Pathol 2006;168:621-8.
4. Sica A, Larghi P, Mancino A, et al. Macrophage polarization in tumour progression. Semin Cancer Biol 2008;18:349-55.
5. Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 2012;122:787-95.
6. Sica A, Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest 2007;117:1155-66.
7. Fuentes-Duculan J, Suarez-Farinas M, Zaba LC, et al. A subpopulation of CD163-positive macrophages is classically activated in psoriasis. J Invest Dermatol 2010;130:2412-22.
8. Bronkhorst IH, Ly LV, Jordanova ES, et al. Detection of M2-macrophages in uveal melanoma and relation with survival. Invest Ophthalmol Vis Sci 2011;52:643-50.
9. Medrek C, Ponten F, Jirstrom K, et al. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. BMC Cancer 2012;12:306.
10. Erreni M, Mantovani A, Allavena P. Tumor-associated macrophages (TAM) and inflammation in colorectal cancer. Cancer Microenviron 2011;4:141-54.
11. Laoui D, Movahedi K, Van Overmeire E, et al. Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions. Int J Dev Biol 2011;55:861-7.
12. Wei Q, Fang W, Ye L, et al. Density of tumor associated macrophage correlates with lymph node metastasis in papillary thyroid carcinoma. Thyroid 2012;130(3):619-24.
13. Furuya M, Tanaka R, Miyagi E, et al. Impaired CXCL4 expression in tumor-associated macrophages (TAMs) of ovarian cancers arising in endometriosis. Cancer Biol Ther 2012;13:671-80.
14. Jia J, Bai Y, Fu K, et al. Expression of allograft inflammatory factor-1 and CD68 in haemangioma: implication in the progression of haemangioma. Br J Dermatol 2008;159:811-19.
15. Sun ZJ, Cai Y, Chen G, et al. LMO2 promotes angiogenesis probably by up-regulation of bFGF in endothelial cells: an implication of its pathophysiological role in infantile haemangioma. Histopathology 2010;57:622-32.
16. Sun ZJ, Chen G, Hu X, et al. Activation of PI3 K/Akt/IKK-alpha/NF-kappaB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma: its inhibition by quercetin. Apoptosis 2010;15:850-63.
17. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006;66:605-12.
18. Ohri CM, Shikotra A, Green RH, et al. The tissue microlocalisation and cellular expression of CD163, VEGF, HLA-DR, iNOS, and MRP 8/14 is correlated to clinical outcome in NSCLC. PLoS One 2011;6:e21874.
19. Wagner M, Bjerkvig R, Wiig H, et al. Inflamed tumor-associated adipose tissue is a depot for macrophages that stimulate tumor growth and angiogenesis. Angiogenesis 2012;15(3):481-95.
20. Guiducci C, Vicari AP, Sangaletti S, et al. Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection. Cancer Res 2005;65:3437-46.
21. Rigo A, Gottardi M, Zamo A, et al. Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12. Mol Cancer 2010;9:273.
22. Kawamura K, Komohara Y, Takaishi K, et al. Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors. Pathol Int 2009;59:300-5.
23. Ohnishi K, Komohara Y, Sakashita N, et al. Macrophages in Langerhans cell histiocytosis are differentiated toward M2 phenotype: their possible involvement in pathological processes. Pathol Int 2010;60:27-34.
24. Cassetta L, Cassol E, Poli G. Macrophage polarization in health and disease. ScientificWorldJournal 2011;11:2391-402.
25. Shirabe K, Mano Y, Muto J, et al. Role of tumor-associated macrophages in the progression of hepatocellular carcinoma. Surg Today 2012;42:1-7.
26. Nguyen VA, Furhapter C, Romani N, et al. Infantile hemangioma is a proliferation of beta 4-negative endothelial cells adjacent to HLA-DR-positive cells with dendritic cell morphology. Hum Pathol 2004;35:739-44.
27. Ding T, Xu J, Wang F, et al. High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection. Hum Pathol 2009;40:381-9.
28. Lue H, Dewor M, Leng L, et al. Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74. Cell Signal 2011;23:135-44.
29. Recalcati S, Locati M, Gammella E, et al. Iron levels in polarized macrophages: Regulation of immunity and autoimmunity. Autoimmun Rev 2012;11(12): 883-9.
30. De Palma M. Partners in crime: VEGF and IL-4 conscript tumour-promoting macrophages. J Pathol 2012;227:4-7.
31. Schraufstatter IU, Zhao M, Khaldoyanidi SK, et al. The chemokine CCL18 causes maturation of cultured monocytes to macrophages in the M2 spectrum. Immunology 2012;135:287-98.
32. Coffelt SB, Tal AO, Scholz A, et al. Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions. Cancer Res 2010;70:5270-80.
33. Medina RJ, O'Neill CL, O'Doherty TM, et al. Myeloid angiogenic cells act as alternative M2 macrophages and modulate angiogenesis through interleukin-8. Mol Med 2011;17:1045-55.
34. Melinceanu L, Sarafoleanu C, Lerescu L, et al. Impact of smoking on the immunological profile of patients with laryngeal carcinoma. J Med Life 2009;2:211-18.
35. Itinteang T, Tan ST, Jia J, et al. Mast cells in infantile haemangioma possess a primitive myeloid phenotype. J Clin Pathol 2013;66:597-600.
36. Itinteang T, Tan ST, Brasch H, et al. Haemogenic endothelium in infantile haemangioma. J Clin Pathol 2010;63:982-6.
37. Itinteang T, Tan ST, Brasch H, et al. Primitive erythropoiesis in infantile haemangioma. Brit J Dermatol 2011;164:1097-100.